Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate methamphetamine bill nearing floor vote, Sen. Hatch tells House hearing.

This article was originally published in The Tan Sheet

Executive Summary

SENATE NEGOTIATIONS ON HATCH METHAMPHETAMINE BILL are "down to one or two little issues" and "hopefully it can pass within a couple of days," Sen. Orrin Hatch (R-Utah) reported at a Sept. 5 hearing on a similar House bill before the House Judiciary Subcommittee on Crime. Introduced July 17, the Hatch bill (S 1965) is intended to help control illegal methamphetamine production through a number of means, including limits on the sale of precursor materials such as pseudoephedrine and phenylpropanolamine (PPA) ("The Tan Sheet" Aug. 12, p. 1).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086004

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel